Kate Farms logo

Kate Farms Funding & Investors

Kate Farms offers nutritionally advanced, plant-based tube feeding, and enteral formulas that are well-tolerated by patients. Free of common allergens, including soy, dairy, and corn, clinicians report patients have experienced decreased symptoms of GI intolerance, improved weight or linear growth, and overall improved nutritional status. Kate Farms is now the #1 plant-based enteral formula on the market. They’re gaining a better understanding of the role nutrition has on health, both in the management of care and direct therapeutic impact. Ingredients matter and our formulas are designed to deliver outcomes that matter. They pair leading-edge science and technologies with ingredients from nature in unique formulations that work with the bodies. This combination offers the potential for significant improvements to health and to the practice of healthcare. Today doctors, dietitians, parents, caregivers, and those with medical and dietary needs are empowered with the choice of a new formula. It’s the nourishment that makes them feel good because everyone deserves nothing less.

katefarms.com

Total Amount Raised: $188,000,000

Kate Farms Funding Rounds

  • Series C

    $75,000,000

    Series C Investors

    Novo Holdings
    Kaiser Permanente Ventures
    Coefficient Capital
    Aliment Capital
    Goldman Sachs Asset Management
    MainStreet Investment Advisors
  • Debt Financing

    $30,000,000

    Debt Financing Investors

    PacWest Bancorp
  • Seed

    $9,000,000

    Seed Investors

    MainStreet Investment Advisors
  • Series B

    $51,000,000

    Series B Investors

    Goldman Sachs
    Kaiser Permanente Ventures
  • Series A

    $23,000,000

    Series A Investors

    William R. Loomis
    Jeff Jacobs
    Robert (Bob) Zollars
    Carol Ammon
    David Roux
    John Hammergren
    Peter M. Nicholas
    Kristin Loomis
    Gregg Engles
    Celeste A. Clark
Funding info provided by Diffbot.